Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Recently published
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI Insight
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewOncology Open Access | 10.1172/jci.insight.144394

PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis

Liwen Li,1 Fan Sun,1 Lei Han,1 Xujie Liu,1 Yadong Xiao,2 Alyssa D. Gregory,2 Steven D. Shapiro,2 Gutian Xiao,1 and Zhaoxia Qu1

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Li, L. in: JCI | PubMed | Google Scholar |

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Sun, F. in: JCI | PubMed | Google Scholar

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Han, L. in: JCI | PubMed | Google Scholar |

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Liu, X. in: JCI | PubMed | Google Scholar

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Xiao, Y. in: JCI | PubMed | Google Scholar

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Gregory, A. in: JCI | PubMed | Google Scholar |

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Shapiro, S. in: JCI | PubMed | Google Scholar

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Xiao, G. in: JCI | PubMed | Google Scholar

1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, United States of America

2Department of Medicine, University of Pittsburgh, Pittsburgh, United States of America

Find articles by Qu, Z. in: JCI | PubMed | Google Scholar

Published February 4, 2021 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.144394.
Copyright © 2021, Li et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published February 4, 2021 - Version history
View PDF
Abstract

One of the most fundamental and challenging questions in the cancer field is how immunity is transformed from tumor immunosurveillance to tumor-promoting inflammation. Here, we identify the tumor suppressor PDZ-LIM domain-containing protein 2 (PDLIM2) as a checkpoint of alveolar macrophages (AMs) important for lung tumor suppression. During lung tumorigenesis, PDLIM2 expression in AMs is down-regulated by reactive oxygen species (ROS)-activated transcription repressor BTB and CNC homology 1 (BACH1). PDLIM2 down-regulation leads to constitutive activation of the transcription factor signal transducer and activator of transcription 3 (STAT3), driving AM pro-tumorigenic polarization/activation and differentiation from monocytes attracted from the circulation to suppress cytotoxic T lymphocytes (CTLs) and promote lung cancer. PDLIM2 down-regulation also decreases AM phagocytosis. These findings establish ROS/BACH1/PDLIM2/STAT3 as a signaling pathway driving AMs for lung tumor promotion.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (February 4, 2021): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI Insight

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement
Follow JCI Insight:
Copyright © 2021 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts